| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.7M | +28.4% |
| Cost of Revenue | $2.3M | -58.5% |
| Gross Profit | $376K | +110.9% |
| R&D Expense | $7.8M | +4.9% |
| SG&A Expense | $9.7M | +81.1% |
| Operating Income | -$21.1M | +1.5% |
| Interest Expense | $1.3M | +36.5% |
| Pre-tax Income | -$51.4M | -174.7% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | +710.2% |
| Accounts Receivable | $349K | +18.7% |
| Inventory | $1.6M | -40.9% |
| Current Assets | $6.4M | +57.7% |
| Total Assets | $100.6M | +1986.4% |
| Current Liabilities | $4.1M | +13.1% |
| Total Liabilities | $14.9M | +53.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.5M | -18.2% |
| Capital Expenditures | $35K | -30.0% |
| Investing Cash Flow | -$1.6M | -3014.0% |
| Financing Cash Flow | $22.0M | +77.6% |
| Free Cash Flow | -$17.6M | -18.0% |
| -100.0% |
| Net Income | -$51.4M | -174.6% |
| EPS (Basic) | -$16.14 | -407.5% |
| EPS (Diluted) | -$16.14 | -407.5% |
| Stockholders' Equity |
| $85.7M |
| +1762.3% |